The National Quality Forum has endorsed quality-improvement measures for multiple cancer types that are being developed into actionable tools to improve cancer care. No nationally endorsed quality metrics currently exist for head and neck cancer. METHODS: The authors identified patients with surgically treated, invasive, head and neck squamous cell carcinoma in the National Cancer Data Base from 2004 to 2014 and compared the rate of adherence to 5 different quality metrics and whether compliance with these quality metrics impacted overall survival. The metrics examined included negative surgical margins, neck dissection lymph node (LN) yield 18, appropriate adjuvant radiation, appropriate adjuvant chemoradiation, adjuvant therapy within 6 weeks, as well as overall quality. RESULTS: In total, 76,853 eligible patients were identified. There was substantial variability in patient-level adherence, which was 80% for negative surgical margins, 73.1% for neck dissection LN yield, 69% for adjuvant radiation, 42.6% for adjuvant chemoradiation, and 44.5% for adjuvant therapy within 6 weeks. Risk-adjusted Cox proportional-hazard models indicated that all metrics were associated with a reduced risk of death: negative margins (hazard ratio 
INTRODUCTION
In 1999, the Institute of Medicine released the report Ensuring Quality Cancer Care, which identified a wide gap between real and ideal cancer care in the United States. 1 That report focused on efforts to improve the delivery of high-quality, evidence-based cancer care and led to the National Quality Forum's establishment of specific measures for a variety of malignancies. Initiatives like the Rapid Quality Reporting System and the Cancer Program Practice Profile Report, which rely on data from the National Cancer Database (NCDB), use these quality metrics to provide actionable and timely information to hospitals.
Despite advances across many different types of malignancy, no quality metrics currently exist for head and neck cancer squamous cell carcinoma (HNSCC), which represents a complex group of neoplasms whose treatment requires a multidisciplinary approach. 2 Unfortunately, treatment of HNSCC in the United States reportedly has poor adherence to evidence-based guidelines, 3 which makes it an ideal disease on which to focus efforts for quality improvement to improve multidisciplinary care.
The objective of the current work was to study measures that could be clinically useful and suitable for widespread adoption that met the following 4 criteria of a valid quality metric. 4 First, a metric must be measureable. Second, a metric must be under the direct influence of care providers. Third, there must be evidence of variable adherence to the metric. Fourth, a metric must meaningfully impact patient outcomes. We identified 5 quality metrics for surgically treated HNSCC that have substantial scientific evidence, are under the influence of care providers, could be measured in the NCDB, and could be rapidly implemented into national quality programs. The purpose of our study was to investigate whether the chosen quality metrics met the last 2 criteria of variable adherence and impact on overall survival, making them suitable for more general adoption.
MATERIALS AND METHODS

Data Source and Patients
We identified adult patients (aged 18 years) in the NCDB who had surgically treated, invasive, nonmetastatic HNSCC of the oral cavity, oropharynx, larynx, or hypopharynx and received treatment from January 1, 2004 to December 31, 2014. The NCDB is a nationwide cancer registry that contains information on all cancers treated at Commission on Cancer hospitals in the United States. The NCDB captures data on approximately 70% of all newly diagnosed cancers using methodology described elsewhere. 5 Patients were selected using International Classification of Diseases for Oncology, Third Edition topography codes for oral cavity, oropharynx, larynx and hypopharynx cancer and for histology (Supporting Table  1 ; see online supporting information). 
Variables
Pathologic staging based on the seventh edition American Joint Committee on Cancer guidelines was used; however, when this was missing for a component of the TNM staging, then clinical staging was substituted. Human papillomavirus (HPV) status was assessed when present in patients with oropharyngeal cancer. Hospital type was based on Commission on Cancer accreditation criteria and was grouped as academic/research or nonacademic/research (including community, comprehensive community, and other programs).
Hospital volume was dichotomized into the highest decile and all other deciles, because one-half of all patients received treatment at hospitals in the highest decile.
Quality-Improvement Measure Adherence
The quality metrics chosen for this study were modeled on those approved by the American Head and Neck Society for oral cavity and larynx cancers, 6 National Comprehensive Cancer Network guidelines for HNSCC, 2 and from other publications examining potential quality metrics in HNSCC 7-13 that could be assessed using existing NCDB data. The specific inclusion and exclusion criteria for the quality metrics examined are detailed in Figure 1 .
2,6-13 We excluded HPV-positive oropharyngeal cancer from the adjuvant radiation and chemoradiation metrics, because the adjuvant treatment of HPV-positive disease is currently debated and is the subject of ongoing prospective trials.
14 Negative margins were defined if there was no evidence of microscopic residual tumor, macroscopic residual tumor, or residual tumor not otherwise specified. We calculated a summary measure of overall quality that included in the denominator all metrics for which a patient was at risk and, in the numerator, all of the metrics for which a patient received recommended care, resulting in a proportion between 0% and 100%, as previously described. 13 For example, a patient with a pT2pN0M0 oral cavity cancer who underwent surgical resection with negative margins and neck dissection with >18 lymph nodes removed would meet 2 of 2 quality metrics. The overall quality was then dichotomized at the median (value, 75%), indicating lower and higher quality of care. 13 
Statistical Analysis
Patient-level adherence to quality-improvement metrics was calculated for each measure. Tests for change in the rate of adherence over time used the Cochran-Armitage trend test Figure 1 . This is a flow diagram of the current study. Superscript numerals refer to the referenced study supporting this quality metric.
2,6-13 HPV indicates human papillomavirus. . Logistic regression models with accompanying odds ratios were used to relate patient, tumor, pathology, and treatment variables to adherence for each metric. Cox proportional-hazard regression models were constructed to predict the hazard ratio (HR) of mortality as a function of the individual quality metric after adjustment for patient, tumor, pathology, and treatment variables. Proportional hazard assumptions were checked for all models. All P values were 2-sided. Comparisons were considered statistically significant if the P value was < .05, in which case, the 95% confidence intervals (CIs) did not include 1. All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) version 24.0 (SPSS, Chicago, Illinois; IBM, Armonk, New York). The Northwestern University Institutional Review Board determined that this study was exempt from review.
RESULTS
In total, 76,853 patients met study inclusion criteria and were included in the cohort. They were treated at 1217 different hospitals. The median age was 61 years, 70% of patients were men, and 87.9% were white. Full patient characteristics are listed in Supporting Table 2 (see online supporting information).
Measure 1: Negative Surgical Margins
Among the patients who had documented surgical margins, 80% achieved negative margins (Fig. 2) . There was no significant change in achieving negative surgical margins over time (P 5 .34). Table 1 contains the results from multiple logistic regression models assessing the association of variables with quality metric adherence. On multivariable analysis, patients were less likely to have negative margins if they were men; aged 75 years; had oropharyngeal, hypopharyngeal, or laryngeal cancer; had higher T-classification and higher lymph node (LN) status; were HPV-positive; had nonprivate insurance; or received treatment at a low-volume or nonacademic center. Median survival was 9.3 years (95% CI, 9.1-9.5 years) versus 7.6 years (7.2-8.0 years) in the negative margin and positive margins groups, respectively. the results from risk-adjusted Cox proportional-hazard regression models. The risk-adjusted model indicates that negative surgical margins carried a reduced risk of mortality (HR, 0.73; 95% CI, 0.71-0.76) (Fig. 3 ).
Measure 2: Neck Dissection Yield 18 LNs
Among the patients who underwent neck dissection, 73.1% achieved the quality metric of 18 LNs excised. The proportion of neck dissections with an LN yield 18 , (E) start of adjuvant therapy within 6 weeks, and (F) overall quality (dichotomized at the median, indicating lower and higher quality of care). Curves were adjusted for age, sex, race, comorbidities, subsite, tumor classification, lymph node status, human papillomavirus status, extracapsular extension, adjuvant therapy, insurance status, hospital type, and hospital volume (log-rank test, P <.001 for all quality metrics). Only 44.5% of patients who required adjuvant radiation met the quality metric and received adjuvant therapy 6 weeks after surgery. Analysis of adherence over time revealed a significant decrease (P < .001) in patient-level adherence from 52% during 2004 through 2005 to only 38.5% during 2012 through 2014. Multivariable analysis revealed that patients were less likely to start adjuvant therapy in 6 weeks if they were women, nonwhite, had comorbidities, had higher T-classification or LN status, had extracapsular extension, had HPV-positive disease, had nonprivate insurance, or received treatment at a highvolume or academic center. Patients were more likely to start adjuvant therapy within 6 weeks of surgery if they were older (aged 65 years) and had oropharyngeal, laryngeal, or hypopharyngeal cancer. Median survival was 10.8 years (95% CI, 10.5-11.2 years) versus 8.3 years (95% CI, 8.0-8.6 years) in the groups that started adjuvant therapy 6 weeks versus > 6 weeks, respectively. Cox proportional-hazard models indicated that starting adjuvant therapy within 6 weeks after surgery was associated with a reduced risk of mortality (HR, 0.92; 95% CI, 0.89-0.96).
Overall Quality
The mean overall quality score for patients on these quality metrics was 70.7%. The overall quality of care increased over time from a mean of 68.6% in 2004 and 2005 to 71.3% in 2012 through 2014 (P < .001).
Patients who received high-quality care were more likely to have laryngeal cancer or to receive treatment at highvolume or academic hospitals. Patients were less likely to receive high-quality care if they were older (aged 75 years), had a higher number of comorbidities, had oropharyngeal cancer, had higher T-classification or LN status, had extracapsular extension, had HPV-positive disease, or had nonprivate insurance. Median survival was 10.2 years (95% CI, 10.0-10.5 years) versus 7.5 years (95% CI, 7.3-7.8 years) in the high-quality and lowquality care groups, respectively. Cox proportional-hazard models indicated that high-quality care was associated with a reduced risk of mortality (HR, 0.81; 95% CI, 0.79-0.83).
Original Article DISCUSSION We sought to evaluate 5 different multidisciplinary quality metrics for HNSCC and determine the baseline national performance of these measures and evaluate their impact on overall mortality. No quality metrics currently exist for HNSCC, and variation in adherence to evidence-based recommendations is reportedly as low as 33%, which is associated with worse outcomes. 3, 15 However, existing efforts to develop quality indicators for HNSCC have focused on avoidance of surgical complications in the acute postoperative period, 16 leaving a need for quality metrics to assess the overall multidisciplinary quality of care.
Measure 1: Negative Surgical Margins
Achieving negative, cancer-free margins has long been the cornerstone of surgical quality. Luryi et al assessed the national incidence of positive margins in T1-T2 oral cavity cancers and observed that the incidence of positive margins by institution varied from 0% to 44%, with an average occurrence of 7.5% of cases. 10 Their study highlighted the variable and substandard delivery of surgical care for oral cavity cancer and proposed the need for negative surgical margins as a quality metric. We expanded on this finding to investigate both the rate of positive margins across HNSCC subsites and its impact on survival. Our results indicated that the national rates of negative margins in all types of HNSCC were only 80%. Furthermore, we observed that that achieving negative surgical margins independently carried a 28% increased adjusted hazard of death. Although this was the highest adherence rate of all the quality metrics studied, there is still significant room for national improvement, especially within nonacademic cancer centers.
Measure 2: Neck Dissection Yield 18 LNs
The number of LNs excised is second measure of surgical quality. A large cohort study indicated that patients with HNSCC had an 18% increased hazard of death if fewer than 18 LNs were yielded in neck dissection. 7 Furthermore, this survival advantage was present in both clinically LN-positive and LN-negative patients. Our results similarly indicated that there was substantial variability in the rate of neck dissection that removed 18 LNs, with only 72.7% of patients achieving this outcome; and we also observed that the removal of 18 LN was associated with improved overall survival.
Measures 3 and 4: Appropriate Postoperative Adjuvant Therapy
Despite, guidelines recommending adjuvant radiation for T3-T4 or N2-B3 disease 2 and level I evidence supporting chemoradiation for positive margins or extracapsular extension, 17, 18 national adherence to recommendations for adjuvant radiation and chemoradiation were previously undetermined. We observed that there was substantial variability in the rate of adjuvant postoperative radiation and chemoradiation, with only 70.5% of patients receiving radiation and only 54.1% receiving adjuvant chemoradiation. Furthermore, our results indicated that appropriate adjuvant radiation and chemoradiation were associated with a 32% and 14% reduced hazard of death, respectively. We also noted that academic cancer centers had lower adherence to both adjuvant radiation and adjuvant chemoradiation compared with other types of cancer facilities. This is the opposite of what we observed for the surgical quality indicators. Although the full reasons for this finding are unclear from the current data, we speculate that 1 reason is that procedures in nonacademic cancer centers may more likely be performed by surgeons who are not head and neck oncologic surgeons; thus, there could be increasing reliance on adjuvant radiation or chemoradiation. Future research is needed to investigate the reasons for this trend. Despite these trends observed in higher compliance with adjuvant therapy in nonacademic centers, the adjusted overall survival was better for patients who received treatment at both academic and high-volume centers. There is also considerable support for initiating adjuvant therapy within 6 weeks after surgery, 12, 17, 18 albeit with insufficient evidence on adherence. We observed that there was poor national attainment of initiating adjuvant therapy within 6 weeks of surgery, and only 44.6% of patients met this metric. Furthermore, this was the only quality metric for which adherence decreased over time; however, we were unable to determine the reasons for this trend. Future research is needed to determine the reasons for this decrease over time in the timely receipt of radiation.
Overall Quality
High-quality care must meaningfully impact patient outcomes; and, in support of this, we observed that overall high-quality care was associated with a 19% reduced hazard of mortality. Similarly, Gourin and colleagues examined the quality of care in elderly patients with laryngeal cancer and observed that high-quality care was associated with improved survival. 13 It is noteworthy that the strongest variable associated with an increased likelihood of receiving high-quality care was the receipt of treatment at a high-volume center. In our study, 90% of hospitals treated < 160 cases over the 10-year period and were identified as low-volume centers, indicating that many hospitals treat only a few patients per year with this disease. One way to increase the overall quality of care may be to "take the volume pledge" and concentrate care in highvolume centers, as has been proposed by leaders of several large hospital systems. 19 If validated in other data sets and/or endorsed by societies that care for patients with HNSCC, then the implications of our findings are substantial. These quality metrics could be rapidly implemented into existing Commission on Cancer quality reporting tools to provide timely and actionable information to cancer centers. Previous quality initiatives have demonstrated that the act of measuring quality and reporting real-time outcomes to providers, along with comparisons of other hospital rates, leads to quality improvement. 20 Implementing these quality initiatives may increase adherence to these quality metrics, leading to significant improvements in the survival of patients with HNSCC.
Limitations
This study has several limitations to consider when interpreting the results. First, like all large database studies, the current study is limited by potential errors in coding. Second, although our study adjusted for HPV status when this was known, HPV status was missing from a substantial proportion of patients. Finally, our study focused on patients who underwent primary surgery and excluded a significant proportion of patients who received definitive radiation or chemoradiation. Further study is needed to determine quality metrics for these patients, such as the time to treatment initiation for definitive chemoradiation 21 or poor radiotherapy compliance. Despite these limitations, the NCDB offers a powerful tool to assess potential quality metrics and also could allow for rapid implementation of these metrics through existing qualityimprovement tools.
CONCLUSIONS HNSCC is among the most common forms of cancer for which there are no established no quality improvement metrics. We identified 5 quality metrics for surgically managed HNSCC including negative surgical margins, neck dissection yield 18 LN, appropriate adjuvant radiation, appropriate adjuvant chemoradiation and adjuvant therapy within 6 weeks of surgery that all meet criteria for a clinically useful quality metric. Adherence to each quality metric was associated with a reduced hazard of death. All 5 metrics are suitable candidates for endorsement by national quality organizations.
